NEC contributes to AI powered Vaccine Design through the EU funded PREPAIR VAC Pandemic Preparedness Project
Electronicsmediavia NewsData.io
AI Vaccine Development – NEC Corporation (NEC; TSE: 6701) today announced its participation in PREPAIR VAC, a Horizon Europe–funded research project aimed at strengthening pandemic preparedness through the application of artificial intelligence (AI) in vaccine design. The grant has been awarded to NEC OncoImmunity AS (NOI)—a wholly owned subsidiary of NEC Bio within NEC Corporation—alongside […]
Headline and summary provided via NewsData.io. The full article and its copyright belong to the original publisher.